UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost immune system against hard-to-treat urinary cancers
Disease control Recruiting nowThis early-phase study tests two drugs, bintrafusp alfa and PDS01ADC, alone or with targeted radiation, in 100 adults with metastatic bladder, kidney, or other non-prostate genitourinary cancers. The goal is to see if the combination can help the immune system fight cancer better…
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Immune drug atezolizumab tested before bladder cancer surgery
Disease control Recruiting nowThis phase 2 trial tests whether the drug atezolizumab can shrink tumors in people with urothelial cancer before they have surgery. Participants receive two doses of atezolizumab, then undergo standard surgery to remove the tumor. Researchers will compare tissue and blood samples…
Matched conditions: UROGENITAL CANCER
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Scientists launch Largest-Ever study of rare bladder and genital cancers
Knowledge-focused Recruiting nowThis study follows 1,100 adults with rare urinary tract cancers, such as unusual bladder, kidney, testicular, or penile cancers. Researchers will collect medical records, blood and tumor samples, and imaging over many years to understand how these cancers grow and respond to trea…
Matched conditions: UROGENITAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC